Futibatinib
CAS 1448169-71-8Small Molecule
Overview
Futibatinib is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL3701238).
Patent & exclusivity (US)
Per the FDA Orange Book (1 approved US product), the latest listed US patent on Futibatinib expires 5 Nov 2039 and exclusivity 30 Sept 2029. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- 1-[(3S)-3-[4-amino-3-[2-(3,5-dimethoxyphenyl)ethynyl]pyrazolo[3,4-d]pyrimidin-1-yl]pyrrolidin-1-yl]prop-2-en-1-one
- Canonical SMILES
- COC1=CC(=CC(=C1)C#CC2=NN(C3=NC=NC(=C23)N)[C@H]4CCN(C4)C(=O)C=C)OC
- InChIKey
- KEIPNCCJPRMIAX-HNNXBMFYSA-N
Verified Supplier Partner
Do you supply Futibatinib? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.